Doctor profile · Federal record
Dr. Mohan Thakuri, MD
Hematology & Oncology Physician (CMS: Internal Medicine) · Hematology (Internal Medicine) Physician · Medical Oncology Physician · Asheville, NC
- NPI 1568446870
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
551 Brevard RD
Asheville, NC 288062316
(828) 212-7021
fax (828) 232-8218 - Mailing address
-
Po Box 749495
Atlanta, GA 303749495
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- January 10, 2023
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- North Carolina #200101145
- Medicaid
- NC #891294W
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568446870. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
77,988
Distinct HCPCS
10
Medicare allowed
$1,921,635
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 14,280 | 13 | $1 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 14,040 | 21 | $47 | |
J9299 |
Injection, nivolumab, 1 mg | 7,820 | 12 | $30 | |
J9271 |
Injection, pembrolizumab, 1 mg | 7,500 | 22 | $54 | |
J0185 |
Injection, aprepitant, 1 mg | 6,760 | 29 | $2 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 6,300 | 18 | $7 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,190 | 18 | $45 | |
J0897 |
Injection, denosumab, 1 mg | 2,280 | 16 | $23 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,000 | 20 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,740 | 72 | $0 |
In context: peer comparison
Among 6 peers in Asheville Hematology & Oncology Physician, average services per provider: 885. This provider delivers 88× the peer median.Open Payments
Industry payments received
All-time total
$129
Transactions
7
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $21.43 | |
| Adaptive Biotechnologies Corporation | 1 | $21.14 | |
| Sobi, INC | 1 | $20.33 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $17.88 | |
| Astellas Pharma US INC | 1 | $17.60 | |
| Janssen Biotech, INC. | 1 | $15.84 | |
| Taiho Oncology, INC. | 1 | $14.99 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
669
Patients
75
Total drug cost
$3,778,586
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxyurea | Generic | 104 | 25 | $2,907 |
| Acyclovir | Generic | 97 | 24 | $1,763 |
| Imbruvica (Ibrutinib) | Brand | 79 | 0 | $1,204,188 |
| Imatinib Mesylate | Generic | 71 | 0 | $19,127 |
| Revlimid (Lenalidomide) | Brand | 54 | 12 | $818,207 |
| Pomalyst (Pomalidomide) | Brand | 49 | 0 | $1,052,464 |
| Venclexta (Venetoclax) | Brand | 40 | 0 | $374,291 |
| Dexamethasone | Generic | 32 | 14 | $1,060 |
| Gabapentin | Generic | 25 | 0 | $449 |
| Methotrexate (Methotrexate Sodium) | Brand | 25 | 0 | $891 |
Frequently asked questions
What is Dr. Mohan Thakuri's medical specialty?
Dr. Mohan Thakuri practices Hematology & Oncology Physician in Asheville, NC.
Where does Dr. Mohan Thakuri practice?
Dr. Mohan Thakuri practices at 551 Brevard RD, Asheville, NC 288062316. Office phone: 8282127021.
What is Dr. Mohan Thakuri's NPI?
Dr. Mohan Thakuri's National Provider Identifier (NPI) is 1568446870, issued by NPPES.
Does Dr. Mohan Thakuri accept Medicare assignment?
Yes. Dr. Mohan Thakuri accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mohan Thakuri commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, nivolumab, 1 mg (HCPCS J9299). Source: CMS Medicare Physician & Other Practitioners file.